On July 31, we discussed Moderna, one of the two big C-19 vaccine manufacturers. We discussed two situations: earnings and the longer-term trend. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:#mRNA Share: Mark W. Guthner, CFA Previous Post Microstrategy Update: MSTRNext PostNVIDIA: NVDA You Might Also Like Natural Gas… The Grand Disappointment December 17, 2018 (XOP) Has Energy Found a Bottom? February 13, 2021 Still Liking CVS February 17, 2021
You Might Also Like Natural Gas… The Grand Disappointment December 17, 2018 (XOP) Has Energy Found a Bottom? February 13, 2021 Still Liking CVS February 17, 2021
